Furthermore, antihuman VEGFR-1 mAB treatment increases the survival of mice injected with acute lymphoblastic leukaemia cells [29] and also inhibits tumour growth of VEGFR-1 positive breast cancer and melanoma xenografts [14]. The gene discussed is FLT1; the disease is acute lymphoblastic leukemia.